Azienda Ospedaliero Universitaria Delle Marche — Clinical Trial Site

297 Registered trials

135 Currently recruiting

Organisation

Azienda Ospedaliero Universitaria Delle Marche

Location

Ancona, Italy

Identifier

ORG-100033050

Address

Via Conca 71, 60126, Italy

Departments

#1304:S.O.D. Clinica di Dermatologia
#1605: S.O.D. Clinica di Cardiologia ed Aritmologia - Dipartimento di Scienze Cardiovascolari
#2600, S.O.D. Clinica di Dermatologia
#2655: S.O.D. Clinica di Dermatologia
#2807: S.O.D. Clinica Medica
#3608:SOD Clinica Medica
#40440: SOD Clinica di Dermatologia
#4104:SOD Clinica di Dermatologia
#93133018:SOD Clinica Oncologica
#98333018:SOD Oncologia Medica
#ITA4:SOD Clinica Oculistica
03901:Oncologia Medica
1203: S.O.D. Clinica Medica
1513: Ematologia
1901: SOD Clinica di Dermatologia
2004:S.O.D. Clinica Medica
2258 S.O.D. Clinica Medica
2400: S.O.D. Clinica di Cardiologia ed Aritmologia
2807: S.O.D. Clinica Medica
2808:SOD Clinica Medica
3107: SOD Clinica Ematologica
3207:S.O.D. Clinica Medica
3213: SOD Clinica di Dermatologia
3608; S.O.D. Clinica Medica
380003: S.O.D. Clinica Oculistica
380007: Clinica di Ematologia
4001: Clinica di Oncologia Medica
4043: S.O.D. Clinica Medica Università degli Studi
4112:Clinica Oncologica
9221:S.O.D. Clinica di Dermatologia
9453:S. C. Clinica di Dermatologia
Allergy Unit
Azienda Ospedaliero Universitaria Delle Marche
Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I( #1)
Cardiac Surgery
Cardiology
Centro Fibrosi Cistica
Clinica Dermatologica
Clinica di Anestesia e Rianimazione
Clinica di Cardiologia e Aritmologia
Clinica di Dermatologia
Clinica di Ematologia
Clinica di Ematologia - AOU Ospedali Riuniti
Clinica di Ematologia - Medicina Interna
Clinica di Endocrinologia, Dipartimento di Specialità Mediche e Chirurgiche
Clinica di Gastroenterologia
Clinica di Neurologia
Clinica di Oncologia Medica
Clinica Ematologica
Clinica Medica
Clinica Neurologica
Clinica Oculistica
Clinica Oncologica
Clinica Psichiatrica
Clinical, Special and Dental Sciences
Department of clinical and Molecular Science
Department of Medical Oncology
Department of Medical Oncology and Head of "Genetic Cancer"
Dermatologia
Dermatologic Clinic- Department of Clinical and Molecular Sciences
Dermatological Clinic
Dermatology
Dipartimento di medicina Interna
Dipartimento di Medicina Sperimentale e Clinica
Dipartimento di emergenza-urgenza ed accettazione (DEA)
Dipartimento di Medicina Interna
Dipartimento di Medicina Interna - Clinica Medica
Dipartimento di Medicina Interna - SOD Clinica Ematologica
Dipartimento di Medicina Interna - SOD Clinica Oncologica
Dipartimento di Medicina Interna – SOD Clinica Oncologica
Dipartimento di Medicina Interna –SOD Clinica Oncologica
Dipartimento di Medicina lnterna - SOD Clinica Oncologica
Dipartimento di Medicina Sperimentale e Clinica
Dipartimento di Medicina Sperimentale e Clinica, Clinica Oculistica
Dipartimento di Medicina Sperimentale e Clinical
Dipartimento di Oncologia Medica
Dipartimento di Scienze Cardiovascolari, SOD Cadiologia Ospedaliera e UTIC
Dipartimento Scienze Cardiovascolari, SOD Cardiologia Ospedaliera e UTIC
Divisione di Pediatria
Dpt Internal Medicine- SOD Clinic Oncology
Dpt Medicina Interna- SOD Clinica Oncologica
Ematologia
Emergency and Internal Medicine
Experimental and Clinical Medicine
Gastroenterolgy and Transplantation
Gastroenterologico e dei Trapianti
Haematology & oncology
Hematology
Hematology Clinic Transplant Unit of stem cells and cell therapy
Hematology Unit
Internal Medicine
Internal Medicine - SOD Hematology Clinic
Internal Medicine Department
Interventional Cardiology Unit
IT10014: Ematologia
Medical oncology
Medical Oncology Deparment
Medicina Intenra - SOD Clinica Oncologica
MEDICINA INTERNA
Medicina Interna - SOD Clinica Medica
Medicina Interna - SOD Clinica Oncologica
Medicina Interna – SOD Clinica Oncologica
MEDICINA INTERNA-SOD CLINICA DI EMATOLOGIA
Medicina Interna, SOD Clinica Ematologica
Medicina Interna, SOD Clinica Oncologica
Medicna Interna- SOD Clinica Oncologica
N/A
NA
Nephrology, Dialysis and Renal Transplant Department
Neurology
Neurology Unit
Oculistica
Oncoematologia Pediatrica
Oncoematologia-Pediatrica
Oncologia
Oncologia Medica
oncology
Patologie Polmonari Infiltrative Diffuse, Pleuriche e delle Bronchiectesie dell'Adulto
Pediatric oncology
Pneumology
Respiratory Medicine
Respiratory Medicine Unit
S.O.D. Clinica di Dermatologia
S.O.D. Clinica Oncologica
Scienze Cardiovascolari- SOD Cardiologia Ospedaliera e UTIC
SOC Clinica medica
SOD CARDIOLOGIA - Dipartimento Scienze Cardiovascolari
SOD Cardiologia Emodinamica e UTIC
SOD Cardiologia Ospedaliera e UTIC
SOD Chirurgia Ricostruttiva e Chirurgia della Mano
SOD Clinica Dermatologica
SOD Clinica di Anestesia e Rianimazione Generale, Respiratoria e del Trauma Maggiore
SOD Clinica di Dermatologia
SOD Clinica di Ematologia
SOD Clinica di Gastroenterologia, Epatologia ed Endoscopia Digestiva d’Urgenza
SOD Clinica Ematologica
SOD Clinica Medica
SOD Clinica Medica - Dipartimento di Medicina Interna
SOD Clinica Oculistica
SOD Clinica Oncologica
SOD Clinica Psichiatrica
SOD Clinical Oncology
SOD dermatology
SOD di Endocrinologia e Malattie del metabolismo
SOD Diabetologia Pediatrica
SOD Hematology Clinic
SOD Nefrologia, Dialisi e Trapianto di Rene
SOD Neonatologia
SOD Neonatology
SOD Oncology Clinic
SOS Fibrosi Cistica
SOSD Diagnosi e Terapia delle Patologie Polmonari Infiltrative Diffuse, Pleuriche e Bronchiectesie
SOSD Diagnosi e Terapia Patologie Polmonari Infiltrative Diffuse Pleuriche e bronchiectasie Adulto
SOSD Diagnosi Terapia delle Pat. polmonari infiltrative diffuse pleuriche,bronchiectasie dell’adulto
SOsD Oncoematologia Pediatrica
SOsD Oncoematologia pediatrica Dipartimento Materno infantile
U.O Experimental and Clinic Medicine
U.O. Dermatologia
UC Oncology
Unità Operativa Complessa di Clinica di Ematologia
UO Clinica Medica

Clinical trials at this site (297)

Search interface

Phase 3 study to assess the efficacy and safety of Givinostat versus hydroxyurea in Polycythemia Vera patients Recruiting

2022-502276-23-00 JAK2V617F-positive high-risk Polycythemia Vera 5 2024-04-25
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Ch… Recruiting

2023-505660-11-00 Cholangiocarcinoma (LTT, 26.0) 5 2024-04-24
Bomedemstat vs Best Available Therapy (BAT) for Essential Thrombocythemia Recruiting

2023-504865-21-00 Essential Thrombocythemia patients who have an inadequa 5 2024-04-15
STUDY OF OP-1250 ADMINSTERED AS MONOTHERAPY AND COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2– ADVANCED OR METASTATIC BREAST C… Recruiting

2023-505871-63-00 ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
A study with new methods to monitor newly diagnosed multiple myeloma in participants being treated with a new treatment combination - TAURUS Recruiting

2023-505221-14-00 Multiple Myeloma 4 2024-04-04
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib… Recruiting

2023-503708-10-00 Locally advanced or metastatic breast cancer 5 2024-02-20
An Open-label Study of XEN1101 in Epilepsy Recruiting

2022-502282-24-00 Primary generalized tonic-clonic seizures 5 2024-02-14
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
AGNOSTIC THERAPY IN A PHASE II, MULTICENTER, SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB (MEDI 4736) IN ASSOCIATION WITH CARBOPLA… Recruiting

2023-505078-13-00 EXTENSIVE STAGE ‐ EXTRAPULMONARY SMALL CELL CARCINOMA 4 2024-01-16
A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RV… Recruiting

2023-505911-19-00 Acute Myeloid Leukemia 4 2024-01-05
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate… Recruiting

2023-503295-25-00 Resectable biliary tract cancers 10 2023-10-31
A Phase 3, prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center study of rotigotine in com… Recruiting

2023-504602-11-00 Mild to moderate Alzheimer's disease 5 2023-10-25
Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting

2022-502281-25-00 Focal Onset Seizures 5 2023-09-27
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Recruiting

2022-502415-11-00 Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) 5 2023-06-16
This study has 2 phases: a Phase 1b evaluation of elacestrant in combination with abemaciclib followed by a Phase 2 evaluation of elacestran… Recruiting

2024-512878-98-00 Brain Metastasis from Estrogen Receptor Positive, HER-2 9 2023-05-16
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors… Recruiting

2024-514266-39-00 Advanced Non-Small Cell Lung Cancer (NSCLC) and Other S 7 2022-11-03
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting

2023-503335-18-00 Chronic myeloid leukemia 1 2022-07-29
A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan… Recruiting

2023-504660-41-00 Cholestatic Pruritus in Patients with Primary Biliary C 4 2022-07-11
An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients wit… Recruiting

2024-511635-94-00 Relapsed or Refractory Plasmablastic lymphoma 4 2022-07-11
Efficacy and safety of subcutaneous dupilumab for the treatment of adult participants with chronic pruritus of unknown origin (CPUO) Recruiting

2023-508879-36-00 Pruritus 5 2022-04-28
A Phase 1/2 Study of the Highly Selective ROS1 Inhibitor NVL-520 in Patients with Advanced NSCLC and Other Solid Tumors (ARROS-1) Recruiting

2024-511793-71-00 Advanced ROS1-positive NSCLC and other advanced ROS1-po 7 2022-02-28
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Treatment with a Vitamin K Antagonist due to having a m 5 2021-10-19